Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
LONGITUDINAL INTENSITY NORMALIZATION IN THE PRESENCE OF MULTIPLE SCLEROSIS LESIONS.
miR-20b Suppresses Th17 Differentiation and the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting RORγt and STAT3.
A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis.
Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination.
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis.
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
Experimental Autoimmune Encephalomyelitis in Marmosets.
Comparative Effects of Human Neural Stem Cells and Oligodendrocyte Progenitor Cells on the Neurobehavioral Disorders of Experimental Autoimmune Encephalomyelitis Mice.
Clinical data and regulatory issues of biosimilar products.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy.
Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders.
Retrograde retinal damage after acute optic tract lesion in MS.
Identifying physical activity information needs and preferred methods of delivery of people with multiple sclerosis.
Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.
Is it possible to detect active multiple sclerosis plaques using MR thermometry techniques?
Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS.
Evaluation of Cytokines in Multiple Sclerosis Patients Treated with Mesenchymal Stem Cells.
Aquaporin-4 antibody negative recurrent isolated optic neuritis: Clinical evidence for disease heterogeneity.
Distinct and Atypical Intrinsic and Extrinsic Cell Death Pathways between Photoreceptor Cell Types upon Specific Ablation of Ranbp2 in Cone Photoreceptors.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.
Can meditation influence quality of life, depression, and disease outcome in multiple sclerosis? Findings from a large international web-based study.
[Pay attention to the differences and similarities in the pathogenesis and management of multiple sclerosis and neuromyelitis optica].
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Pages
« first
‹ previous
…
504
505
506
507
508
509
510
511
512
…
next ›
last »